These data demonstrate the critical role of stromal AR in Gli1-lineage cells, acting as a tumor niche to support prostate epithelial tumorigenesis and implicate the underlying mechanisms for hormone refractoriness and CRPC development through dysregulation of stromal AR on IGFBP3-IGF1 signaling during ADT therapies. This evidence concerns the gene GLI1 and neoplasm.